For: | Eksi YE, Sanlioglu AD, Akkaya B, Ozturk BE, Sanlioglu S. Genome engineering and disease modeling via programmable nucleases for insulin gene therapy: Promises of CRISPR/Cas9 technology . World J Stem Cells 2021; 13(6): 485-502 [PMID: 34249224 DOI: 10.4252/wjsc.v13.i6.485] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v13/i6/485.htm |
Number | Citing Articles |
1 |
Busra Cetin, Fulya Erendor, Yunus E. Eksi, Ahter D. Sanlioglu, Salih Sanlioglu. Gene and cell therapy of human genetic diseases: Recent advances and future directions. Journal of Cellular and Molecular Medicine 2024; 28(17) doi: 10.1111/jcmm.70056
|
2 |
Mona Mohamed Ibrahim Abdalla. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges. World Journal of Gastroenterology 2024; 30(40): 4339-4353 doi: 10.3748/wjg.v30.i40.4339
|
3 |
Yunus Emre Eksi, Atil Bisgin, Ahter D. Sanlioglu, Reha Onur Azizoglu, Mustafa Kemal Balci, Thomas S. Griffith, Salih Sanlioglu. Cell Biology and Translational Medicine, Volume 18. Advances in Experimental Medicine and Biology 2022; 1409: 145 doi: 10.1007/5584_2022_746
|
4 |
Zeyu Tian, Tao Yu, Jun Liu, Ting Wang, Akon Higuchi. Stem Cell in Medicine. Progress in Molecular Biology and Translational Science 2023; 199: 3 doi: 10.1016/bs.pmbts.2023.02.012
|
5 |
Jonathan Waataja, Sayeed Ikramuddin, Dov Gal, Charles Billington. Type 2 Diabetes in 2024 - From Early Suspicion to Effective Management. 2023; doi: 10.5772/intechopen.1002713
|